| 臺北醫學大學 |
2005 |
In Vitro activities of tigecycline, ertapenem,isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan.
|
劉永慶; Cheng NC; Hsueh PR; Liu YC; Shyr JM; Huang WK; Teng LJ; Liu CY |
| 國立成功大學 |
2007-02 |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Hung, Min-Nan; Hsueh, Po-Ren; Chang, Hou-Tai; Lee, Wen-Sen; Chou, Ming-Yuan; Chen, Ing-Shen; Wang, Jen-Hsien; Lin, Chen-Fu; Shyr, Jainn-Ming; Ko, Wen-Chien; Wu, Jiunn-Jong; Liu, Yung-Ching; Huang, Wen-Kuei; Teng, Lee-Jene; Liu, Cheng-Yi; Luh, Kwen-Tay |
| 國立臺灣大學 |
2007 |
In Vitro Activities of Various Piperacillin and Sulbactam Combinations against Bacterial Pathogens Isolated from Intensive Care Units in Taiwan: Smart 2004 Programme Data
|
洪敏南; 薛博仁; 張厚台; 周明淵; 王任賢; 石建民; 柯文謙; 吳俊忠; 劉永慶; 黃文貴; 鄧麗珍; 劉正義; 陸坤泰; HUNG, MIN-NAN; HSUEH, PO-REN; CHANG, HOU- TAI; CHOU, MING-YUAN; WANG, JEN-HSIEN; SHYR, JAINN-MING; KO, WEN-CHIEN; WU, JIUNN-JONG; LIU, YUNG-CHIN; HUANG, WEN-KUEI; TENG, LEE-JENE; LIU, CHENG-YI; LUH, KWEN-TAY |
| 臺大學術典藏 |
2018-09-10T06:16:32Z |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Hung, M.-N. and Hsueh, P.-R. and Chang, H.-T. and Lee, W.-S. and Chou, M.-Y. and Chen, I.-S. and Wang, J.-H. and Lin, C.-F. and Shyr, J.-M. and Ko, W.-C. and Wu, J.-J. and Liu, Y.-C. and Huang, W.-K. and Teng, L.-J. and Liu, C.-Y. and Luh, K.-T.; PO-REN HSUEH; LEE-JENE TENG |
| 臺大學術典藏 |
2020-03-27T05:30:29Z |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Chang H.-T.; Lee W.-S.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; Teng L.-J.; Liu C.-Y.; Luh K.-T.; PO-REN HSUEH; Hung M.-N.; Luh K.-T.;Liu C.-Y.;Teng L.-J.;Huang W.-K.;Liu Y.-C.;Wu J.-J.;Ko W.-C.;Shyr J.-M.;Lin C.-F.;Wang J.-H.;Chen I.-S.;Chou M.-Y.;Lee W.-S.;Chang H.-T.;PO-REN HSUEH;Hung M.-N. |
| 臺大學術典藏 |
2020-12-18T08:39:20Z |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Luh K.-T.; Liu C.-Y.; Teng L.-J.; Huang W.-K.; Liu Y.-C.; Wu J.-J.; Ko W.-C.; Shyr J.-M.; Lin C.-F.; Wang J.-H.; Hung M.-N.; PO-REN HSUEH; Chang H.-T.; Lee W.-S.; Chou M.-Y.; Chen I.-S. |
| 臺大學術典藏 |
2021-05-26T03:34:53Z |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Hung M.-N.; Hsueh P.-R.; Chang H.-T.; Lee W.-S.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; Teng L.-J.; Liu C.-Y.; KWEN-TAY LUH |
| 臺北醫學大學 |
2007 |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from intensive care units in Taiwan: SMART 2004 programme data.
|
李文生; Hung MN; Hsueh PR; Chang HT; Lee WS; Chou MY; Chen IS; Wang JH; Lin CF; Shyr JM; Ko WC; Wu JJ; Liu YC; Huang WK; Teng LJ; Liu CY; Luh KT |
| 臺北醫學大學 |
2007 |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from intensive care units in Taiwan: SMART 2004 programme data.
|
劉永慶; Hung MN; Hsueh PR; Chang HT; Lee WS; Chou MY; Chen IS; Wang JH; Lin CF; Shyr JM; Ko WC; Wu JJ; Liu YC; Huang WK; Teng LJ; Liu CY; Luh KT |
| 臺北醫學大學 |
2006 |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan:SMART 2004 programme data
|
Min-Nan Hung;Po-Ren Hsueh;Hou-Tai Chang;Wen-Sen Lee;Ming-Yuan Chou;Ing-Shen Chen;Jen-Hsien Wang;Chen-Fu Lin;Jainn-Ming Shyr;Wen-Chien Ko;Jiunn-Jong Wu;Yung-Ching Liu;Wen-Kuei Huang;Lee-Jene Teng;Cheng-Yi Liu;Kwen-Tay Luh |
| 國立臺灣大學 |
1993 |
In Vitro Activity of Antimicrobial Agents, Alone and in Combination, Against Acinetobacter Baumannii Isolated from Blood
|
張上淳; 陳宜君; Luh, K. T.; 謝維銓; 張上淳; 陳宜君; Luh, K. T.; Hsieh, Wei-Chuan |
| 國立臺灣大學 |
2002-12 |
In vitro activity of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw, SJ; Teng, LJ; Ho, SW; Luh, KT; Hsueh, PR. |
| 國立成功大學 |
2022 |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodst
|
Liu, P.-Y.;Ko, W.-C.;Lee, W.-S.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Lu, M.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Shao, P.-L.;Lee, Y.-L.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Hsueh, P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:41Z |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
|
Liu P.-Y.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Lee Y.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 嘉南藥理大學 |
2019 |
In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
|
Lai, Chih-Cheng; Chen, Chi-Chung; Lu, Ying-Chen; Chuang, Yin-Ching; Tang, Hung-Jen |
| 國立成功大學 |
2020-04-1 |
In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017)
|
Ko;Wen-Chien;Stone;Gregory, Gregory G. |
| 國立成功大學 |
2018 |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean, S.-S.;Lu, M.-C.;Shi, Z.-Y.;Tseng, S.-H.;Wu, T.-S.;Lu, P.-L.;Shao, P.-L.;Ko, W.-C.;Wang, F.-D.;Hsueh, P.-R. |
| 臺大學術典藏 |
2020-03-27T05:28:35Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
PO-REN HSUEH;Wang F.-D.;Ko W.-C.;Shao P.-L.;Lu P.-L.;Wu T.-S.;Tseng S.-H.;Shi Z.-Y.;Lu M.-C.;Jean S.-S.; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH |
| 臺大學術典藏 |
2021-05-06T08:25:58Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; PEI-LAN SHAO; Ko W.-C.; Wang F.-D.; Hsueh P.-R. |
| 臺大學術典藏 |
2020-12-18T08:37:10Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean S.-S.;Lu M.-C.;Shi Z.-Y.;Tseng S.-H.;Wu T.-S.;Lu P.-L.;Shao P.-L.;Ko W.-C.;Wang F.-D.;Po-Ren Hsueh; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH |
| 臺北醫學大學 |
1998 |
In vitro activity of ciprofloxacin against Mycobacterium tuberculosis
|
白冠壬; Ming-Chih Yu; Tzong-Fei Ong; Jen Suo; Kuan-Jen Bai; Tao-Ping Lin |
| 嘉南藥理大學 |
2015 |
In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1
|
Tang, Hung-Jen; Ku, Yee-Huang; Lee, Mei-Feng; Chuang, Yin-Ching; Yu, Wen-Liang |
| 國立成功大學 |
2023 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020
|
Chang, Chang C.-Y.;Lee, Y.-L.;Huang, Y.-T.;Ko, W.-C.;Ho, M.-W.;Hsueh, P.-R. |
| 國立成功大學 |
2023 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales from patients with intra-abdominal infections: Results of the study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2020
|
Lee, Y.-L.;Ko, W.-C.;Hsueh, P.-R. |
| 國立成功大學 |
2023 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020
|
Liu, Y.-M.;Ko, W.-C.;Ho, M.-W.;Lee, Y.-L.;Hsueh, P.-R. |
